Talk:Abdala (vaccine)
This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||
|
Daily pageviews of this article
A graph should have been displayed here but graphs are temporarily disabled. Until they are enabled again, visit the interactive graph at pageviews.wmcloud.org |
Question about source of this statement[edit]
I just was wondering what the source for the statement "on May 1, 97% of the original participants had received their 3 doses, the others 3% were lost in the process" was, and also what that statement means exactly. I am not positive who added that bit. — Preceding unsigned comment added by Beebah dooba (talk • contribs) 02:18, 23 June 2021 (UTC)
It's me that added this part but essentially of the original participants that received their first dose, 97% received their 3rd doses while 3% didn't. --Tech-ScienceAddict (talk) 13:25, 28 June 2021 (UTC)
Please describe your changes[edit]
Recently, a part saying results weren't released to the public has been removed. No justification. I will reput it in a better writen way but please justify your changes. --Tech-ScienceAddict (talk) 13:30, 28 June 2021 (UTC)
Categories:
- C-Class COVID-19 articles
- Mid-importance COVID-19 articles
- WikiProject COVID-19 articles
- C-Class medicine articles
- Mid-importance medicine articles
- All WikiProject Medicine articles
- C-Class pharmacology articles
- Mid-importance pharmacology articles
- WikiProject Pharmacology articles
- C-Class Cuba articles
- Low-importance Cuba articles
- WikiProject Cuba articles